Eleonora Chiossi

2.4k total citations · 2 hit papers
11 papers, 1.6k citations indexed

About

Eleonora Chiossi is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrine and Autonomic Systems. According to data from OpenAlex, Eleonora Chiossi has authored 11 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pulmonary and Respiratory Medicine and 2 papers in Endocrine and Autonomic Systems. Recurrent topics in Eleonora Chiossi's work include Pulmonary Hypertension Research and Treatments (5 papers), Cardiovascular Issues in Pregnancy (3 papers) and Cardiovascular Disease and Adiposity (2 papers). Eleonora Chiossi is often cited by papers focused on Pulmonary Hypertension Research and Treatments (5 papers), Cardiovascular Issues in Pregnancy (3 papers) and Cardiovascular Disease and Adiposity (2 papers). Eleonora Chiossi collaborates with scholars based in Switzerland, Netherlands and Italy. Eleonora Chiossi's co-authors include Nazzareno Galiè, Rolf M.F. Berger, Maurice Beghetti, Michael J. Landzberg, Andrea Lauer, Michael Α. Gatzoulis, John Granton, Andjela Kusic‐Pajic, Pavel Jansa and Hikmet Al‐Hiti and has published in prestigious journals such as The Lancet, Circulation and CHEST Journal.

In The Last Decade

Eleonora Chiossi

11 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

2008 647 citations Nazzareno Galiè, LJ Rubin et al. The Lancet profile →
Bosentan Therapy in Patients With Eisenmenger Syndrome

2006 578 citations Nazzareno Galiè, Maurice Beghetti et al. Circulation profile →

Peers

Eleonora Chiossi

PRM

CCM

EPIDE

GENET

Qin Luo China

Annie C. Lajoie Canada

Friedrich C. Blumberg Germany

Caroline O’Connell France

Vincent T. Miller United States

Ying‐Chih Huang Taiwan

Jacek Kądziela Poland

Takashi Kohno Japan

Katrin Meyer Germany

M Haguenau France

Qin Luo China

Eleonora Chiossi

569 ×0.4

PRM

463 ×0.4

CCM

87 ×0.2

EPIDE

89 ×0.4

GENET

25 ×0.2

Citations per year, relative to Eleonora Chiossi Eleonora Chiossi (= 1×) peers Qin Luo

Countries citing papers authored by Eleonora Chiossi

Since Specialization

Citations

This map shows the geographic impact of Eleonora Chiossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Chiossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Chiossi more than expected).

Fields of papers citing papers by Eleonora Chiossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleonora Chiossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Chiossi. The network helps show where Eleonora Chiossi may publish in the future.

Co-authorship network of co-authors of Eleonora Chiossi

This figure shows the co-authorship network connecting the top 25 collaborators of Eleonora Chiossi. A scholar is included among the top collaborators of Eleonora Chiossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleonora Chiossi. Eleonora Chiossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Hoever, Petra, Sanne Lysbet de Haas, Georg Dorffner, et al.. (2012). Orexin receptor antagonism: an ascending multiple-dose study with almorexant. Journal of Psychopharmacology. 26(8). 1071–1080. 64 indexed citations

Lebrec, Didier, Jaime Bosch, Rajiv Jalan, et al.. (2011). Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis. European Journal of Clinical Pharmacology. 68(5). 533–541. 19 indexed citations

Hoever, Petra, Julia Winkler, Rik C. Schoemaker, et al.. (2010). Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant. Clinical Pharmacology & Therapeutics. 87(5). 593–600. 85 indexed citations

Sidharta, Patricia N., Klaus Rave, Lutz Heinemann, et al.. (2009). Effect of the urotensin‐II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus. British Journal of Clinical Pharmacology. 68(4). 502–510. 21 indexed citations

Berger, Rolf M.F., Maurice Beghetti, Nazzareno Galiè, et al.. (2009). Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: A subgroup analysis. International Journal of Cardiology. 144(3). 373–378. 52 indexed citations

Galiè, Nazzareno, LJ Rubin, Marius M. Hoeper, et al.. (2008). Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. The Lancet. 371(9630). 2093–2100. 647 indexed citations breakdown →

Gatzoulis, Michael Α., Maurice Beghetti, Nazzareno Galiè, et al.. (2007). Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: Results of the BREATHE-5 open-label extension study. International Journal of Cardiology. 127(1). 27–32. 155 indexed citations

Galiè, Nazzareno, Maurice Beghetti, Michael Α. Gatzoulis, et al.. (2006). Bosentan Therapy in Patients With Eisenmenger Syndrome. Circulation. 114(1). 48–54. 578 indexed citations breakdown →

Gatzoulis, M., Maurice Beghetti, Nazzareno Galiè, et al.. (2006). Bosentan shows persistent benefit in functional class and exercise capacity amongst Eisenmenger patients in the BREATHE-5 open label extension study. European Heart Journal. 27. 8–9. 1 indexed citations

10.

Galiè, Nazzareno, Lewis J. Rubin, Marius M. Hoeper, et al.. (2006). CORRELATION OF WHO FUNCTIONAL CLASS AND INDICES OF DISEASE SEVERITY IN IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION: INSIGHTS FROM EARLY, BREATHE-1 AND 351 STUDIES. CHEST Journal. 130(4). 254S–254S. 1 indexed citations

11.

Galiè, Nazzareno, Maurice Beghetti, Michael Α. Gatzoulis, et al.. (2005). BREATHE-5: BOSENTAN IMPROVES HEMODYNAMICS AND EXERCISE CAPACITY IN THE FIRST RANDOMIZED PLACEBO-CONTROLLED TRIAL IN EISENMENGER PHYSIOLOGY. CHEST Journal. 128(4). 496S–496S. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact